Breaking the Mould — GlaxoSmithKline full-year results
Breaking the Mould — GlaxoSmithKline full-year results
Russ Mould, AJ Bell's Investment Director discusses GlaxoSmithKline, due to report full-year results on 3 February. He also looks at the first meeting of the Bank of England’s monetary policy committee.